S&P closes at 10-week high on vaccine hopes, stimulus pledge; Dow up 3.8%
Drugmaker Moderna Inc surged 19.96 per cent after the company said its experimental COVID-19 vaccine showed promising results in a small early-stage trial
)
Explore Business Standard
Drugmaker Moderna Inc surged 19.96 per cent after the company said its experimental COVID-19 vaccine showed promising results in a small early-stage trial
)
Already subscribed? Log in
Subscribe to read the full story →
3 Months
₹300/Month
1 Year
₹225/Month
2 Years
₹162/Month
Renews automatically, cancel anytime
Over 30 premium stories daily, handpicked by our editors


News, Games, Cooking, Audio, Wirecutter & The Athletic
Digital replica of our daily newspaper — with options to read, save, and share


Insights on markets, finance, politics, tech, and more delivered to your inbox
In-depth market analysis & insights with access to The Smart Investor


Repository of articles and publications dating back to 1997
Uninterrupted reading experience with no advertisements


Access Business Standard across devices — mobile, tablet, or PC, via web or app
First Published: May 19 2020 | 3:09 AM IST